tirzepatide in type 1 diabetes Can improve insulin resistance diabetes? Researchers at the Victor Chang Cardiac Research Institute are launching the TIRTLE2 Study, aimed at improving metabolism and insulin resistance in individuals with Beyond glycemia: Comparing tirzepatide to

Sometimes you need a positive boost to jumpstart your efforts and motivate you to keep going

Adding glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism alongside GLP-1R creates a genuinely different metabolic research profile not just an incremental improvement

Enhance muscle repair and support anti-aging benefits

Although the therapeutic indication was not reported in half of the ICSRs, 37.3% indicated that semaglutide was used for weight control or obesity, highlighting that in most cases the potentially counterfeit product was used for its weight loss effect rather than for the treatment of diabetes mellitus, underscoring the growing interest in their use (Gasoyan et al., 2025)